These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2544930)

  • 1. CCK-antagonist L-364,718: influence on rat pancreatic growth induced by caerulein and bombesin-like peptides.
    Schmidt WE; Choudhury AR; Siegel EG; Löser C; Conlon JM; Fölsch UR; Creutzfeldt W
    Regul Pept; 1989 Jan; 24(1):67-79. PubMed ID: 2544930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a new potent CCK antagonist, lorglumide, on caerulein- and bombesin-induced pancreatic secretion and growth in the rat.
    Scarpignato C; Varga G; Dobronyi I; Papp M
    Br J Pharmacol; 1989 Mar; 96(3):661-9. PubMed ID: 2470456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas.
    Dembinski A; Jaworek J; Konturek PK; Konturek SJ; Warzecha Z
    J Physiol; 1989 Apr; 411():419-35. PubMed ID: 2614728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a new CCK-receptor antagonist, CR 1409, on pancreatic growth induced by caerulein, CCK-8, bombesin and gastrin-releasing peptide in the rat.
    Hajri A; Aprahamian M; Damgé C
    Digestion; 1989; 43(1-2):66-72. PubMed ID: 2806757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of chronic bombesin, gastrin-releasing peptide and caerulein on the rat pancreas.
    Damgé C; Hajri A; Lhoste E; Aprahamian M
    Regul Pept; 1988 Feb; 20(2):141-50. PubMed ID: 2452459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antagonist of receptors for gastrin, cholecystokinin and bombesin on growth of gastroduodenal mucosa and pancreas.
    Dembiński A; Warzecha Z; Konturek SJ; Banas M; Cai RZ; Schally AV
    J Physiol Pharmacol; 1991 Sep; 42(3):263-77. PubMed ID: 1665365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of cholecystokinin in peptide-YY release in response to pancreatic juice diversion.
    Guan D; Rivard N; Maouyo D; Gettys TW; Morisset J
    Regul Pept; 1993 Feb; 43(3):169-76. PubMed ID: 8441822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-related involvement of CCK in bombesin-induced pancreatic growth.
    Liehr RM; Reidelberger RD; Rosewicz S; Bussjaeger LJ; Solomon TE
    Regul Pept; 1992 Apr; 38(3):207-19. PubMed ID: 1375383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of endogenous cholecystokinin released by bombesin and trypsin inhibitor on the regeneration of the pancreas.
    Parekh D; Ishizuka J; Townsend CM; Rajaraman S; Thompson JC
    Ann Surg; 1993 Dec; 218(6):735-41. PubMed ID: 8257223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The cholecystokinin antagonist L-364,718 inhibits the action of cholecystokinin but not bombesin on rat pancreatic secretion in vivo.
    Anderson L; Dockray GJ
    Eur J Pharmacol; 1988 Feb; 146(2-3):307-11. PubMed ID: 3371402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of CCK antagonist L-364,718, pancreastatin (33-49) and a somatostatin analogue on camostate-induced rat pancreatic hypertrophy.
    Schmidt WE; Stöckmann F; Choudhury AR; Wilms HM; Siegel EG; Nustede R; Fölsch UR; Creutzfeldt W
    Digestion; 1989; 44(2):105-16. PubMed ID: 2612749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of bombesin-induced pancreatic secretion in unanesthetized rats.
    Liehr RM; Reidelberger RD; Varga G; Solomon TE
    Peptides; 1993; 14(4):717-23. PubMed ID: 8234015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of neuromedin B and neuromedin C on exocrine and endocrine rat pancreas.
    Otsuki M; Fujii M; Nakamura T; Tani S; Oka T; Yajima H; Baba S
    Am J Physiol; 1987 Apr; 252(4 Pt 1):G491-8. PubMed ID: 2436486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of CCK receptor antagonists on rat pancreatic secretion in vivo.
    Niederau M; Niederau C; Strohmeyer G; Grendell JH
    Am J Physiol; 1989 Jan; 256(1 Pt 1):G150-7. PubMed ID: 2463767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of repeated administration of bombesin on rat pancreatic secretion.
    Stock-Damgé C; Lhoste E; Aprahamian M; Loza E
    Pancreas; 1987; 2(6):658-63. PubMed ID: 3438303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of bombesin on pancreatic digestive enzyme gene expression.
    Rosewicz S; Liehr RM; Solomon TE; Riecken EO; Logsdon CD
    Endocrinology; 1992 Mar; 130(3):1451-8. PubMed ID: 1371450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic administration of a potent cholecystokinin receptor antagonist, L-364,718, fails to inhibit pancreas growth in preweanling rats.
    Wisner JR; Ozawa S; Xue BG; Renner IG
    Pancreas; 1990 Jul; 5(4):434-8. PubMed ID: 1696382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C antagonizes neuromedin C-stimulated amylase release by acini isolated from the rat pancreas.
    Wisner JR; Xue BG; Coy DH; Renner IG
    Pancreas; 1990 Jul; 5(4):408-14. PubMed ID: 1696379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic neuromedin C stimulates exocrine pancreatic secretion in dogs and rats.
    Hosotani R; Inoue K; Kogire M; Suzuki T; Otsuki M; Rayford PL; Yajima H; Tobe T
    Pancreas; 1987; 2(4):414-21. PubMed ID: 2442749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouse.
    Vasar E; Harro J; Lang A; Pôld A; Soosaar A
    Psychopharmacology (Berl); 1991; 105(3):393-9. PubMed ID: 1798834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.